These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

217 related items for PubMed ID: 18281594

  • 1. First in vivo evidence for a functional interaction between chemokine and cannabinoid systems in the brain.
    Benamar K, Geller EB, Adler MW.
    J Pharmacol Exp Ther; 2008 May; 325(2):641-5. PubMed ID: 18281594
    [Abstract] [Full Text] [Related]

  • 2. CB1 receptor activation in the basolateral amygdala produces antinociception in animal models of acute and tonic nociception.
    Hasanein P, Parviz M, Keshavarz M, Javanmardi K.
    Clin Exp Pharmacol Physiol; 2007 May; 34(5-6):439-49. PubMed ID: 17439413
    [Abstract] [Full Text] [Related]

  • 3. CB1 receptors in the preoptic anterior hypothalamus regulate WIN 55212-2 [(4,5-dihydro-2-methyl-4(4-morpholinylmethyl)-1-(1-naphthalenyl-carbonyl)-6H-pyrrolo[3,2,1ij]quinolin-6-one]-induced hypothermia.
    Rawls SM, Cabassa J, Geller EB, Adler MW.
    J Pharmacol Exp Ther; 2002 Jun; 301(3):963-8. PubMed ID: 12023525
    [Abstract] [Full Text] [Related]

  • 4. Signaling pathways from cannabinoid receptor-1 activation to inhibition of N-methyl-D-aspartic acid mediated calcium influx and neurotoxicity in dorsal root ganglion neurons.
    Liu Q, Bhat M, Bowen WD, Cheng J.
    J Pharmacol Exp Ther; 2009 Dec; 331(3):1062-70. PubMed ID: 19752241
    [Abstract] [Full Text] [Related]

  • 5. A novel role of cannabinoids: implication in the fever induced by bacterial lipopolysaccharide.
    Benamar K, Yondorf M, Meissler JJ, Geller EB, Tallarida RJ, Eisenstein TK, Adler MW.
    J Pharmacol Exp Ther; 2007 Mar; 320(3):1127-33. PubMed ID: 17194800
    [Abstract] [Full Text] [Related]

  • 6. Cannabinoid CB(2) receptor activation prevents bronchoconstriction and airway oedema in a model of gastro-oesophageal reflux.
    Cui YY, D'Agostino B, Risse PA, Marrocco G, Naline E, Zhang Y, Chen HZ, Finance O, Rinaldi-Carmona M, Rossi F, Advenier C.
    Eur J Pharmacol; 2007 Nov 14; 573(1-3):206-13. PubMed ID: 17643417
    [Abstract] [Full Text] [Related]

  • 7. Cannabinoid receptor agonists inhibit Ca(2+) influx to synaptosomes from rat brain.
    Yoshihara S, Morimoto H, Ohori M, Yamada Y, Abe T, Arisaka O.
    Pharmacology; 2006 Nov 14; 76(4):157-62. PubMed ID: 16446560
    [Abstract] [Full Text] [Related]

  • 8. Characterization of cannabinoid agonists and apparent pA2 analysis of cannabinoid antagonists in rhesus monkeys discriminating Delta9-tetrahydrocannabinol.
    McMahon LR.
    J Pharmacol Exp Ther; 2006 Dec 14; 319(3):1211-8. PubMed ID: 16943255
    [Abstract] [Full Text] [Related]

  • 9. The role of cannabinoid receptors in intestinal motility, defaecation and diarrhoea in rats.
    Izzo AA, Mascolo N, Pinto L, Capasso R, Capasso F.
    Eur J Pharmacol; 1999 Nov 12; 384(1):37-42. PubMed ID: 10611417
    [Abstract] [Full Text] [Related]

  • 10. Anandamide-mediated CB1/CB2 cannabinoid receptor--independent nitric oxide production in rabbit aortic endothelial cells.
    McCollum L, Howlett AC, Mukhopadhyay S.
    J Pharmacol Exp Ther; 2007 Jun 12; 321(3):930-7. PubMed ID: 17379772
    [Abstract] [Full Text] [Related]

  • 11. Physiological evidence for interaction between the HIV-1 co-receptor CXCR4 and the cannabinoid system in the brain.
    Benamar K, Yondorf M, Geller EB, Eisenstein TK, Adler MW.
    Br J Pharmacol; 2009 Aug 12; 157(7):1225-31. PubMed ID: 19558543
    [Abstract] [Full Text] [Related]

  • 12. Non-opioid antinociception produced by brain stem injections of improgan: significance of local, but not cross-regional, cannabinoid mechanisms.
    Hough LB, Svokos K, Nalwalk JW.
    Brain Res; 2009 Jan 09; 1247():62-70. PubMed ID: 18983834
    [Abstract] [Full Text] [Related]

  • 13. The cannabinoid CB1 receptor antagonist SR 141716A reverses the antiemetic and motor depressant actions of WIN 55, 212-2.
    Darmani NA.
    Eur J Pharmacol; 2001 Oct 26; 430(1):49-58. PubMed ID: 11698062
    [Abstract] [Full Text] [Related]

  • 14. Cannabinoid receptor agonists inhibit sensory nerve activation in guinea pig airways.
    Yoshihara S, Morimoto H, Yamada Y, Abe T, Arisaka O.
    Am J Respir Crit Care Med; 2004 Nov 01; 170(9):941-6. PubMed ID: 15306537
    [Abstract] [Full Text] [Related]

  • 15. Regulation of inflammatory pain by inhibition of fatty acid amide hydrolase.
    Naidu PS, Kinsey SG, Guo TL, Cravatt BF, Lichtman AH.
    J Pharmacol Exp Ther; 2010 Jul 01; 334(1):182-90. PubMed ID: 20375198
    [Abstract] [Full Text] [Related]

  • 16. Periaqueductal grey CB1 cannabinoid and metabotropic glutamate subtype 5 receptors modulate changes in rostral ventromedial medulla neuronal activities induced by subcutaneous formalin in the rat.
    de Novellis V, Mariani L, Palazzo E, Vita D, Marabese I, Scafuro M, Rossi F, Maione S.
    Neuroscience; 2005 Jul 01; 134(1):269-81. PubMed ID: 15953687
    [Abstract] [Full Text] [Related]

  • 17. Changes in cannabinoid receptor subtype 1 activity and interaction with metabotropic glutamate subtype 5 receptors in the periaqueductal gray-rostral ventromedial medulla pathway in a rodent neuropathic pain model.
    Palazzo E, Luongo L, Bellini G, Guida F, Marabese I, Boccella S, Rossi F, Maione S, de Novellis V.
    CNS Neurol Disord Drug Targets; 2012 Mar 01; 11(2):148-61. PubMed ID: 22483283
    [Abstract] [Full Text] [Related]

  • 18. Pharmacological characterisation of cannabinoid receptors inhibiting interleukin 2 release from human peripheral blood mononuclear cells.
    Ihenetu K, Molleman A, Parsons M, Whelan C.
    Eur J Pharmacol; 2003 Mar 19; 464(2-3):207-15. PubMed ID: 12620515
    [Abstract] [Full Text] [Related]

  • 19. Differences in the relative potency of SR 141716A and AM 251 as antagonists of various in vivo effects of cannabinoid agonists in C57BL/6J mice.
    McMahon LR, Koek W.
    Eur J Pharmacol; 2007 Aug 13; 569(1-2):70-6. PubMed ID: 17553486
    [Abstract] [Full Text] [Related]

  • 20. Evaluation of the cannabinoid CB2 receptor-selective antagonist, SR144528: further evidence for cannabinoid CB2 receptor absence in the rat central nervous system.
    Griffin G, Wray EJ, Tao Q, McAllister SD, Rorrer WK, Aung MM, Martin BR, Abood ME.
    Eur J Pharmacol; 1999 Jul 14; 377(1):117-25. PubMed ID: 10448934
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.